top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
President Trump signed an executive order to accelerate research and expand clinical access to psychedelic therapies like psilocybin and MDMA for veterans and patients with mental health conditions. The order directs federal agencies to streamline clinical trials, provides $50 million for state-level ibogaine research, and establishes a process for rescheduling approved substances.

New Executive Order Fast-Tracks Psychedelic Treatments for Mental Health Wellness

Apr 18, 2026

Source:

Tom Angell

Marijuana Moment

The federal government is signaling a massive shift in how it views alternative therapies, and this latest move is a major win for advocates of plant-based and psychedelic medicine. President Trump has officially signed an executive order designed to fast-track research and clinical access to psychedelics like psilocybin, MDMA, and ibogaine. By directing the FDA to clear away bureaucratic red tape and providing $50 million for state-level research, the administration is essentially opening the doors for these substances to be treated as legitimate medical tools rather than strictly prohibited contraband.

For those of us who follow the cannabis industry closely, this development feels incredibly familiar and deeply relevant. The order specifically highlights the potential for these treatments to help veterans and those struggling with severe mental health challenges, such as PTSD and treatment-resistant depression. It’s a huge leap toward a more compassionate, science-first approach to wellness. The directive even includes a plan for "fast rescheduling" of any psychedelic drugs that receive FDA approval, which could bypass the years of stagnation we’ve often seen with other substances.

Why does this matter to the average enthusiast? Because it further breaks down the walls of prohibition and "Reefer Madness" stigma. As the government begins to acknowledge the medical utility of psychedelics, it reinforces the idea that natural compounds have a seat at the table in modern healthcare. This movement toward transparency and accessibility means that, eventually, we could see more integrated wellness options at the community level.

Practical tip: If you or someone you know is interested in these emerging therapies, keep an eye on "Right to Try" pathways and upcoming clinical trials. While these aren't available at your local shop just yet, the bridge between research and retail is being built right now. This is a moment to celebrate the growing momentum for a future where personal wellness and plant-based science go hand-in-hand.

Recent Reviews

bottom of page